Abstract
Background
Studies on the impact of secondary lymphedema on patient-reported satisfaction and quality of life following postmastectomy breast reconstruction are limited by their heterogeneity. We aimed to reduce heterogeneity in study sample populations and compare BREAST-Q Reconstruction Module scores of patients with lymphedema matched to patients without lymphedema.
Methods
We identified patients who underwent postmastectomy breast reconstruction from 2009 to 2017 and performed a propensity score-matched analysis to compare patient-reported outcomes of patients who developed lymphedema with those who did not. Matched covariates included age, body mass index, race/ethnicity, smoking history, radiation or chemotherapy exposure, postoperative infection, and reconstruction modality and laterality. Outcomes of interest were pre- and postoperative BREAST-Q scores for Satisfaction with Breasts, Physical Well-being of the Chest, Sexual Well-Being, and Psychosocial Well-Being; the minimal clinically important difference (MCID) was four points.
Results
Matched cohorts included 322 patients per group. Preoperative BREAST-Q scores did not differ between lymphedema and non-lymphedema matched cohorts. Postoperative BREAST-Q scores were significantly lower in lymphedema patients: Physical Well-Being of the Chest (all time points), Satisfaction with Breast (at 1 and 2 years), Sexual Well-Being (at 2 years), and Psychosocial Well-Being (at 2 and 3 years). All significant differences in average scores were greater than the MCID.
Conclusions
Patients with breast cancer-related lymphedema reported significantly lower Physical Well-Being of the Chest, Satisfaction with Breasts, Sexual Well-Being, and Psychosocial Well-Being at various time points. Our findings may prove useful for patient counseling and justify the need for further research on the prevention and treatment of this devastating disease.
Similar content being viewed by others
References
Dayan JH, Ly CL, Kataru RP, Mehrara BJ. Lymphedema: pathogenesis and novel therapies. Annu Rev Med. 2018;69:263–76. https://doi.org/10.1146/annurev-med-060116-022900.
DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. https://doi.org/10.1016/s1470-2045(13)70076-7.
Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7(1):83–92. https://doi.org/10.1007/s11764-012-0247-5.
Koslow S, Pharmer LA, Scott AM, et al. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol. 2013;20(11):3422–9. https://doi.org/10.1245/s10434-013-3026-2.
Cereijo-Garea C, Pita-Fernández S, Acea-Nebril B, et al. Predictive factors of satisfaction and quality of life after immediate breast reconstruction using the BREAST-Q©. J Clin Nurs. 2018;27(7–8):1464–74. https://doi.org/10.1111/jocn.14291.
Mülkoğlu C, Ayhan F, Erel S. Sexual functions and quality of life in patients developing lymphedema after total mastectomy: a pilot study. Lymphat Res Biol. 2022;20(2):220–7. https://doi.org/10.1089/lrb.2020.0053.
Jørgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sørensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021;7(1):70. https://doi.org/10.1038/s41523-021-00276-y.
Fish ML, Grover R, Schwarz GS. Quality-of-life outcomes in surgical vs nonsurgical treatment of breast cancer-related lymphedema: a systematic review. JAMA Surg. 2020;155(6):513–9. https://doi.org/10.1001/jamasurg.2020.0230.
Togawa K, Ma H, Smith AW, et al. Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors. Sci Rep. 2021;11(1):10701. https://doi.org/10.1038/s41598-021-89055-0.
Sackey H, Johansson H, Sandelin K, et al. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery. Eur J Surg Oncol. 2015;41(4):577–84. https://doi.org/10.1016/j.ejso.2014.12.006.
Hormes JM, Bryan C, Lytle LA, et al. Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology. 2010;43(1):1–13.
Bulley C, Gaal S, Coutts F, et al. Comparison of breast cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life. Biomed Res Int. 2013. https://doi.org/10.1155/2013/807569.
Nelson JA, Allen RJ Jr, Polanco T, et al. Long-term patient-reported outcomes following postmastectomy breast reconstruction: an 8-year examination of 3268 patients. Ann Surg. 2019;270(3):473–83. https://doi.org/10.1097/sla.0000000000003467.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345–53. https://doi.org/10.1097/PRS.0b013e3181aee807.
Chen CM, Cano SJ, Klassen AF, et al. Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J. 2010;16(6):587–97. https://doi.org/10.1111/j.1524-4741.2010.00983.x.
Chu JJ, Shamsunder MG, Yin S, et al. Propensity scoring in plastic surgery research: an analysis and best practice guide. Plast Reconstr Surg Glob Open. 2022;10(2):e4003.
Brorson H, Höijer P. Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment. J Plast Surg Hand Surg. 2012;46(6):410–5. https://doi.org/10.3109/2000656x.2012.714785.
Voineskos SH, Klassen AF, Cano SJ, Pusic AL, Gibbons CJ. Giving meaning to differences in BREAST-Q scores: minimal important difference for breast reconstruction patients. Plast Reconstr Surg. 2020;145(1):11e–20e. https://doi.org/10.1097/prs.0000000000006317.
De Brucker B, Zeltzer A, Seidenstuecker K, Hendrickx B, Adriaenssens N, Hamdi M. Breast cancer-related lymphedema: quality of life after lymph node transfer. Plast Reconstr Surg. 2016;137(6):1673–80. https://doi.org/10.1097/prs.0000000000002169.
Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg. 2018;32(1):12–6. https://doi.org/10.1055/s-0038-1635117.
Santosa KB, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL. Long-term patient-reported outcomes in postmastectomy breast reconstruction. JAMA Surg. 2018;153(10):891–9. https://doi.org/10.1001/jamasurg.2018.1677.
Basta MN, Wu LC, Kanchwala SK, et al. Reliable prediction of postmastectomy lymphedema: the risk assessment tool evaluating lymphedema. Am J Surg. 2017;213(6):1125-33.e1. https://doi.org/10.1016/j.amjsurg.2016.08.016.
Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208–17. https://doi.org/10.1089/lrb.2005.3.208.
Wiser I, Mehrara BJ, Coriddi M, et al. Preoperative assessment of upper extremity secondary lymphedema. Cancers (Basel). 2020;12(1):135. https://doi.org/10.3390/cancers12010135.
Speck RM, Gross CR, Hormes JM, et al. Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Cancer Res Treat. 2010;121(2):421–30. https://doi.org/10.1007/s10549-009-0550-7.
Devulapalli C, Bello RJ, Moin E, et al. The effect of radiation on quality of life throughout the breast reconstruction process: a prospective, longitudinal pilot study of 200 patients with long-term follow-up. Plast Reconstr Surg. 2018;141(3):579–89. https://doi.org/10.1097/prs.0000000000004105.
Acknowledgment
The authors would like to acknowledge Dagmar Schnau for her contributions towards editing and preparing this manuscript.
Funding
This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748, which supports Memorial Sloan Kettering Cancer Center’s research infrastructure.
Author information
Authors and Affiliations
Contributions
MC contributed substantially to this study, including study conception and design; data analysis and interpretation; manuscript drafting and revisions; and approval of the final version. LNK contributed to data collection, analysis, and interpretation; manuscript drafting and revisions; and approval of final version. KH contributed to data analysis and interpretation; manuscript drafting and revisions; and approval of final version. LM contributed to data collection and analysis and approval of final version. MGS contributed to data analysis and interpretation, and approval of final version. BJM contributed to study conception and design; data analysis and interpretation; manuscript drafting and revisions; and approval of the final version. JHD contributed to study design and conception; manuscript drafting and revisions; and approval of final version. JAN contributed to study conception and design; data analysis and interpretation; manuscript drafting and revisions; and approval of the final version.
Corresponding authors
Ethics declarations
Disclosures
Joseph H. Dayan is a paid consultant for Stryker Corporation and the director of Welwaze Corporation. Babak Mehrara is a consultant for PureTech Corporation and receives research funding from Regeneron. Michelle Coriddi, Leslie N. Kim, Kathryn Haglich, Leslie McGrath, Jasmine J.L. Monge, Meghana G. Shamsunder and Jonas A. Nelson have no disclosures to declare, financial or otherwise.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Coriddi, M., Kim, L.N., Haglich, K. et al. The Impact of Lymphedema on Patient-Reported Outcomes After Breast Reconstruction: A Preliminary Propensity Score-Matched Analysis. Ann Surg Oncol 30, 3061–3071 (2023). https://doi.org/10.1245/s10434-022-12994-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12994-z